BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 17018624)

  • 21. Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development.
    Shoji Y; Takahashi M; Kitamura T; Watanabe K; Kawamori T; Maruyama T; Sugimoto Y; Negishi M; Narumiya S; Sugimura T; Wakabayashi K
    Gut; 2004 Aug; 53(8):1151-8. PubMed ID: 15247185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
    Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
    J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor and antimetastatic activities of 4-hydroxyderricin isolated from Angelica keiskei roots.
    Kimura Y; Taniguchi M; Baba K
    Planta Med; 2004 Mar; 70(3):211-9. PubMed ID: 15114497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1.
    Wang JW; Peng SY; Li JT; Wang Y; Zhang ZP; Cheng Y; Cheng DQ; Weng WH; Wu XS; Fei XZ; Quan ZW; Li JY; Li SG; Liu YB
    Cancer Lett; 2009 Aug; 281(1):71-81. PubMed ID: 19299076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals.
    Hidvégi M; Ráso E; Tömösközi-Farkas R; Paku S; Lapis K; Szende B
    Anticancer Res; 1998; 18(4A):2353-8. PubMed ID: 9703878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual Action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen.
    Sava G; Zorzet S; Turrin C; Vita F; Soranzo M; Zabucchi G; Cocchietto M; Bergamo A; DiGiovine S; Pezzoni G; Sartor L; Garbisa S
    Clin Cancer Res; 2003 May; 9(5):1898-905. PubMed ID: 12738748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Participation of prostaglandin E receptor EP4 subtype in duodenal bicarbonate secretion in rats.
    Aoi M; Aihara E; Nakashima M; Takeuchi K
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G96-103. PubMed ID: 15194560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cells.
    Herynk MH; Stoeltzing O; Reinmuth N; Parikh NU; Abounader R; Laterra J; Radinsky R; Ellis LM; Gallick GE
    Cancer Res; 2003 Jun; 63(11):2990-6. PubMed ID: 12782608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma.
    Kawajiri H; Yashiro M; Shinto O; Nakamura K; Tendo M; Takemura S; Node M; Hamashima Y; Kajimoto T; Sawada T; Ohira M; Hirakawa K
    Clin Cancer Res; 2008 May; 14(9):2850-60. PubMed ID: 18451253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulation of lymphocytic cholinergic activity by ONO-4819, a selective prostaglandin EP4 receptor agonist, in MOLT-3 human leukemic T cells.
    Suenaga A; Fujii T; Ogawa H; Maruyama T; Ohuchida S; Katsube N; Obata T; Kawashima K
    Vascul Pharmacol; 2004 Mar; 41(2):51-8. PubMed ID: 15196475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of EP4 prostaglandin E2 receptor in the ischemic liver.
    Kuzumoto Y; Sho M; Ikeda N; Mizuno T; Hamada K; Akashi S; Tsurui Y; Kashizuka H; Nomi T; Kanehiro H; Nakajima Y
    Transplant Proc; 2005; 37(1):422-4. PubMed ID: 15808664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells.
    Oh JM; Kim SH; Lee YI; Seo M; Kim SY; Song YS; Kim WH; Juhnn YS
    Carcinogenesis; 2009 Jan; 30(1):141-9. PubMed ID: 18849297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PGE2-receptor subtype EP4-dependent adherence of mastocytoma P-815 cells to matrix components in subcutaneous tissues overlaying inside surface of air pouch cavity in CDF1 mouse.
    Kataoka H; Sakanaka M; Semma M; Yamamoto T; Hirota S; Tanaka S; Ichikawa A
    Inflamm Res; 2008 Aug; 57(8):362-6. PubMed ID: 18787774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin E2 stimulates VEGF expression in primary rat gastric fibroblasts through EP4 receptors.
    Hatazawa R; Tanigami M; Izumi N; Kamei K; Tanaka A; Takeuchi K
    Inflammopharmacology; 2007 Oct; 15(5):214-7. PubMed ID: 17943254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative cyclooxygenase 2 inhibition to reduce tumor cell adhesion and metastatic potential of circulating tumor cells in non-small cell lung cancer.
    Backhus LM; Sievers E; Lin GY; Castanos R; Bart RD; Starnes VA; Bremner RM
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):297-303. PubMed ID: 16872953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of vascular endothelial growth factor receptor inhibitor SU5416 and prostacyclin on murine lung metastasis.
    Cuneo KC; Fu A; Osusky KL; Geng L
    Anticancer Drugs; 2007 Mar; 18(3):349-55. PubMed ID: 17264769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a selective agonist for prostaglandin E receptor subtype EP4 (ONO-4819) on the cortical bone response to mechanical loading.
    Hagino H; Kuraoka M; Kameyama Y; Okano T; Teshima R
    Bone; 2005 Mar; 36(3):444-53. PubMed ID: 15777678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation.
    Yoshida K; Oida H; Kobayashi T; Maruyama T; Tanaka M; Katayama T; Yamaguchi K; Segi E; Tsuboyama T; Matsushita M; Ito K; Ito Y; Sugimoto Y; Ushikubi F; Ohuchida S; Kondo K; Nakamura T; Narumiya S
    Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4580-5. PubMed ID: 11917107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.